Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16


Characterization and outcomes of reinterventions in Food and Drug Administration-approved versus trial endovascular aneurysm repair devices.

Fairman AS, Wang GJ, Jackson BM, Foley PJ, Damrauer SM, Kalapatapu V, Golden MA, Fairman RM.

J Vasc Surg. 2018 Apr;67(4):1082-1090. doi: 10.1016/j.jvs.2017.08.058. Epub 2017 Oct 23.


An innovative biologic system for photon-powered myocardium in the ischemic heart.

Cohen JE, Goldstone AB, Paulsen MJ, Shudo Y, Steele AN, Edwards BB, Patel JB, MacArthur JW Jr, Hopkins MS, Burnett CE, Jaatinen KJ, Thakore AD, Farry JM, Truong VN, Bourdillon AT, Stapleton LM, Eskandari A, Fairman AS, Hiesinger W, Esipova TV, Patrick WL, Ji K, Shizuru JA, Woo YJ.

Sci Adv. 2017 Jun 14;3(6):e1603078. doi: 10.1126/sciadv.1603078. eCollection 2017 Jun.


Biochemically engineered stromal cell-derived factor 1-alpha analog increases perfusion in the ischemic hind limb.

Edwards BB, Fairman AS, Cohen JE, MacArthur JW Jr, Goldstone AB, Woo JB, Hiesinger W, Woo YJ.

J Vasc Surg. 2016 Oct;64(4):1093-9. doi: 10.1016/j.jvs.2015.06.140. Epub 2015 Sep 12.


A Tissue-Engineered Chondrocyte Cell Sheet Induces Extracellular Matrix Modification to Enhance Ventricular Biomechanics and Attenuate Myocardial Stiffness in Ischemic Cardiomyopathy.

Shudo Y, Cohen JE, MacArthur JW, Goldstone AB, Otsuru S, Trubelja A, Patel J, Edwards BB, Hung G, Fairman AS, Brusalis C, Hiesinger W, Atluri P, Hiraoka A, Miyagawa S, Sawa Y, Woo YJ.

Tissue Eng Part A. 2015 Oct;21(19-20):2515-25. doi: 10.1089/ten.TEA.2014.0155. Epub 2015 Sep 18.


Non-resectional leaflet remodeling mitral valve repair preserves leaflet mobility: A quantitative echocardiographic analysis of mitral valve configuration.

Shudo Y, Cohen JE, MacArthur JW, Goldstone AB, Hiraoka A, Howard J, Fairman AS, Patel J, Edwards BB, Atluri P, Woo YJ.

Int J Cardiol. 2015;186:16-8. doi: 10.1016/j.ijcard.2015.03.239. Epub 2015 Mar 18. No abstract available.


Evaluation of late aortic insufficiency with continuous flow left ventricular assist device†.

Hiraoka A, Cohen JE, Shudo Y, MacArthur JW Jr, Howard JL, Fairman AS, Atluri P, Kirkpatrick JN, Woo YJ.

Eur J Cardiothorac Surg. 2015 Sep;48(3):400-6. doi: 10.1093/ejcts/ezu507. Epub 2015 Feb 3.


A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy.

Cohen JE, Purcell BP, MacArthur JW Jr, Mu A, Shudo Y, Patel JB, Brusalis CM, Trubelja A, Fairman AS, Edwards BB, Davis MS, Hung G, Hiesinger W, Atluri P, Margulies KB, Burdick JA, Woo YJ.

Circ Heart Fail. 2014 Jul;7(4):619-26. doi: 10.1161/CIRCHEARTFAILURE.113.001273. Epub 2014 Jun 5.


Bioengineered stromal cell-derived factor-1α analogue delivered as an angiogenic therapy significantly restores viscoelastic material properties of infarcted cardiac muscle.

Trubelja A, MacArthur JW, Sarver JJ, Cohen JE, Hung G, Shudo Y, Fairman AS, Patel J, Edwards BB, Damrauer SM, Hiesinger W, Atluri P, Woo YJ.

J Biomech Eng. 2014 Aug;136(8). doi: 10.1115/1.4027731.


Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1α analog in a translational ovine myocardial infarction model.

Macarthur JW Jr, Cohen JE, McGarvey JR, Shudo Y, Patel JB, Trubelja A, Fairman AS, Edwards BB, Hung G, Hiesinger W, Goldstone AB, Atluri P, Wilensky RL, Pilla JJ, Gorman JH 3rd, Gorman RC, Woo YJ.

Circ Res. 2014 Feb 14;114(4):650-9. doi: 10.1161/CIRCRESAHA.114.302884. Epub 2013 Dec 23.


Continuous flow left ventricular assist device implant significantly improves pulmonary hypertension, right ventricular contractility, and tricuspid valve competence.

Atluri P, Fairman AS, MacArthur JW, Goldstone AB, Cohen JE, Howard JL, Zalewski CM, Shudo Y, Woo YJ.

J Card Surg. 2013 Nov;28(6):770-5. doi: 10.1111/jocs.12214. Epub 2013 Sep 30.


Normalization of postinfarct biomechanics using a novel tissue-engineered angiogenic construct.

Atluri P, Trubelja A, Fairman AS, Hsiao P, MacArthur JW, Cohen JE, Shudo Y, Frederick JR, Woo YJ.

Circulation. 2013 Sep 10;128(11 Suppl 1):S95-104. doi: 10.1161/CIRCULATIONAHA.112.000368.


Spatially oriented, temporally sequential smooth muscle cell-endothelial progenitor cell bi-level cell sheet neovascularizes ischemic myocardium.

Shudo Y, Cohen JE, Macarthur JW, Atluri P, Hsiao PF, Yang EC, Fairman AS, Trubelja A, Patel J, Miyagawa S, Sawa Y, Woo YJ.

Circulation. 2013 Sep 10;128(11 Suppl 1):S59-68. doi: 10.1161/CIRCULATIONAHA.112.000293.


Nonresectional single-suture leaflet remodeling for degenerative mitral regurgitation facilitates minimally invasive mitral valve repair.

MacArthur JW Jr, Cohen JE, Goldstone AB, Fairman AS, Edwards BB, Hornick MA, Atluri P, Woo YJ.

Ann Thorac Surg. 2013 Nov;96(5):1603-6. doi: 10.1016/j.athoracsur.2013.05.053. Epub 2013 Aug 7.


Predicting right ventricular failure in the modern, continuous flow left ventricular assist device era.

Atluri P, Goldstone AB, Fairman AS, MacArthur JW, Shudo Y, Cohen JE, Acker AL, Hiesinger W, Howard JL, Acker MA, Woo YJ.

Ann Thorac Surg. 2013 Sep;96(3):857-63; discussion 863-4. doi: 10.1016/j.athoracsur.2013.03.099. Epub 2013 Jun 21.


Mathematically engineered stromal cell-derived factor-1α stem cell cytokine analog enhances mechanical properties of infarcted myocardium.

MacArthur JW Jr, Trubelja A, Shudo Y, Hsiao P, Fairman AS, Yang E, Hiesinger W, Sarver JJ, Atluri P, Woo YJ.

J Thorac Cardiovasc Surg. 2013 Jan;145(1):278-84. doi: 10.1016/j.jtcvs.2012.09.080.


Rapid onset of fulminant myocarditis portends a favourable prognosis and the ability to bridge mechanical circulatory support to recovery.

Atluri P, Ullery BW, MacArthur JW, Goldstone AB, Fairman AS, Hiesinger W, Acker MA, Woo YJ.

Eur J Cardiothorac Surg. 2013 Feb;43(2):379-82. doi: 10.1093/ejcts/ezs242. Epub 2012 May 7.


Supplemental Content

Loading ...
Support Center